Abstract
Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.4103/ijh.ijh_37_21
Copy DOIJournal: Iraqi Journal of Hematology | Publication Date: Jan 1, 2022 |
License type: cc-by-nc-sa |
Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.